<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> X and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> share many metabolic and morphological similarities with <z:e sem="disease" ids="C0010481" disease_type="Disease or Syndrome" abbrv="">Cushing's syndrome</z:e>, a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> caused by systemic <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> excess </plain></SENT>
<SENT sid="1" pm="."><plain>Pathologies frequently associated with these diseases include <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, <z:hpo ids='HP_0002719'>susceptibility to infection</z:hpo>, <z:hpo ids='HP_0001058'>poor wound healing</z:hpo>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The similarity of the clinical profiles associated with these disorders suggests the influence of a common molecular mechanism for disease <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Interestingly, numerous studies identify <z:chebi fb="7" ids="17761">ceramides</z:chebi> and other <z:chebi fb="0" ids="26739">sphingolipids</z:chebi> as potential contributors to these sequelae </plain></SENT>
<SENT sid="4" pm="."><plain>Herein we review studies demonstrating that aberrant <z:chebi fb="7" ids="17761">ceramide</z:chebi> accumulation contributes to the development of the deleterious clinical manifestations associated with these diseases </plain></SENT>
</text></document>